Butterfly Medical raises $21M for Benign Prostatic Hyperplasia device

Funding
Butterfly Medical announced that it completed its Series C funding round, bringing in $21 million to support its BPH treatment. The company develops the Butterfly device, a first-line interventional therapy for benign prostatic hyperplasia (BPH)....

Butterfly Medical raises $21M for Benign Prostatic Hyperplasia device

Funding
Butterfly Medical announced that it completed its Series C funding round, bringing in $21 million to support its BPH treatment. The company develops the Butterfly...

NVision raises $55M to expand from quantum MRI

Funding
NVision has raised $55 million in a Series B funding round led by Abbott as it expands from quantum sensing into quantum computing technology...

UroMems raises $60M strategic investment from Ajax Health Fund I

Funding
UroMems, a global company developing innovative, implantable mechatronics technology to treat stress urinary incontinence (SUI), announced it has raised a $60 million strategic investment,...

NVision raises $55М to expand from quantum MRI

Funding
NVision has raised $55 million in a Series B funding round led by Abbott as it expands from quantum sensing into quantum computing technology...

Get Weekly Newsletter

[hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

Finance

Funding

Clinical Trials

Reprieve Cardiovascular pilot study backs heart failure system

Reprieve Cardiovascular announced the publication of results from a pilot study of its heart failure therapy. Milford, Massachusetts-based Reprieve Cardiovascular develops the Reprieve Therapy. It...

MMI completes first robotic-assisted procedure in Alzheimer’s patient

Medical Microinstruments (MMI) announced the completion of the first robotic-assisted procedure in its REMIND U.S. IDE study. REMIND evaluates microsurgical intervention for neurodegenerative disease. MMI...

CVRx enrolls first patient in study of Barostim therapy for heart failure

CVRx announced that it enrolled the first patient in its landmark BENEFIT-HF study of its Barostim therapy. Barostim delivers electrical pulses to baroreceptors in the...

Sensome reports positive findings for clot-sensing guidewire

Sensome announced the publication of first-in-human results from the CLOT OUT study evaluating its Clotild smart guidewire system. Findings published in the Journal of Neurointerventional...

Innovation

Regulatory Approvals

Butterfly Medical raises $21M for Benign Prostatic Hyperplasia device

Butterfly Medical announced that it completed its Series C funding round, bringing in $21 million to support its BPH treatment. The company develops the Butterfly...

NVision raises $55M to expand from quantum MRI

NVision has raised $55 million in a Series B funding round led by Abbott as it expands from quantum sensing into quantum computing technology...

UroMems raises $60M strategic investment from Ajax Health Fund I

UroMems, a global company developing innovative, implantable mechatronics technology to treat stress urinary incontinence (SUI), announced it has raised a $60 million strategic investment,...

NVision raises $55М to expand from quantum MRI

NVision has raised $55 million in a Series B funding round led by Abbott as it expands from quantum sensing into quantum computing technology...

M&A

Archives

Latest articles

Load more

Popular categories

Funding1136Regulatory Approvals1016Innovation655Clinical Trials520Mergers & Acquisitions506GS Funding Tracker49